Skip to content
MedBioinformatics
  • About
  • Services
    • NLP
    • AI & Knowledge Graphs
  • Blog
  • Contact
  • About
  • Services
    • NLP
    • AI & Knowledge Graphs
  • Blog
  • Contact

Browse more

Recent Posts

  • MedBioinformatics Announces Participation in IHI JU VICT3R Initiative to Revolutionize Nonclinical Drug and Chemical Safety Evaluation with Virtual Controls
  • Genetics In Drug Discovery: The Key To Clinical Trial Success?
  • DISGENET Academic License: Eligibility, Application & Free Access
  • How DISGENET Uses NLP To Accelerate Drug Development
  • DISGENET Rebrand: A Fresh Look, Same Reliable Data for Tomorrow

Archives

  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • September 2023
  • March 2023
  • October 2022
  • May 2022

Categories

  • Article
  • Interview
  • News
  • Product

Tags

AI drug discovery software AI in healthcare am I eligible for the disgenet academic license? bioinformatics clinical trial success DISGENET disgenet.com disgenet academic license disgenet academic plans DISGENET for academics drug approvals drug development drug development software drug discovery drug repurposing drugs drug target selection FDA FDA approved drugs 2023 free access disgenet gene disease database genetic genetics genetic support for drug approvals genomics how is NLP used in drug discovery? human genetics improving drug target selection natural language processing new disgenet NLP NLP healthcare VICT3R VICT3R initiative

  • Launch of IHI JU VICT3R Initiative to Revolutionize Nonclinical Drug and Chemical Safety Evaluation with Virtual Controls

    MedBioinformatics Announces Participation in IHI JU VICT3R Initiative to Revolutionize Nonclinical Drug and Chemical Safety Evaluation with Virtual Controls

    News September 16, 2024

    [Barcelona, Spain, September 16, 2024] — MedBioinformatics today announced its involvement in the VICT3R initiative, a groundbreaking initiative aimed at transforming nonclinical drug and chemical safety evaluation. VICT3R is a public-private partnership supported by the Innovative Health Initiative Joint Undertaking (IHI JU), set to significantly reduce the number of animals used in experimental studies. The […]


Footer Logo
  • Contact
  • Careers
  • Privacy Policy
  • Cookies Policy
  • LinkedIn
  • YouTube
  • Mail

© Copyright 2025. MedBioinformatics Solutions.

Creativity & Web: Krieen